Silo Pharma, Inc. SEC filings SILO

Silo Pharma, Inc. has 378 filings in SEC EDGAR's recent list, going back to Mar 30, 2011. Its latest annual report, Form ARS, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Silo Pharma, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale
Oct 14, 2026 Oct 13, 2026
8-K Current report
Material agreement, Unregistered share sale
Oct 2, 2026 Oct 1, 2026
8-K Current report
Material agreement, Unregistered share sale
Aug 19, 2026 Aug 18, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Aug 17, 2026 Aug 14, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 13, 2026 Jul 9, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 17, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jun 3, 2026 Jun 1, 2026
8-K Current report
Other events
Jun 1, 2026 Jun 1, 2026
8-K Current report
Material agreement, Unregistered share sale
Apr 2, 2026 Mar 30, 2026
8-K Current report
Unregistered share sale, Other events
Feb 23, 2026 Feb 20, 2026
8-K Current report
Listing notice
Dec 29, 2025 Dec 24, 2025
8-K Current report
Officer or director change, Shareholder vote results
Oct 24, 2025 Oct 24, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 1, 2025 Sep 29, 2025
8-K Current report
Other events
Aug 5, 2025 Aug 4, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 29, 2025 Jul 29, 2025
8-K Current report
Material agreement
Jul 10, 2025 Jul 8, 2025
8-K Current report
Listing notice
Jul 3, 2025 Jun 27, 2025
8-K Current report
Material agreement, Other events
May 16, 2025 May 15, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 10, 2025 Mar 10, 2025
8-K Current report
Other events
Mar 7, 2025 Mar 4, 2025
8-K Current report
Other events
Jan 2, 2025 Jan 2, 2025
8-K Current report
Shareholder vote results
Dec 20, 2024 Dec 20, 2024
8-K Current report
Other events
Nov 8, 2024 Nov 8, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 10, 2024 Sep 10, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 22, 2024 Jul 18, 2024
8-K Current report
Material agreement, Other events
Jul 8, 2024 Jul 1, 2024
8-K Current report
Material agreement
Jun 27, 2024 Jun 26, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 6, 2024 Jun 4, 2024
8-K Current report
Other events
Jun 4, 2024 Jun 4, 2024
8-K Current report
Other events
Apr 5, 2024 Apr 4, 2024
8-K Current report
Other events
Feb 1, 2024 Feb 1, 2024
8-K/A Amended current report
Other events
Jan 11, 2024 Jan 9, 2024
8-K Current report
Other events
Jan 9, 2024 Jan 9, 2024
8-K Current report
Shareholder vote results
Dec 11, 2023 Dec 11, 2023
8-K Current report
Bylaw or fiscal year change, Other events
Dec 5, 2023 Dec 4, 2023
8-K Current report
Shareholder vote results
Dec 4, 2023 Dec 4, 2023
8-K Current report
Material agreement
Nov 14, 2023 Nov 10, 2023
8-K Current report
Other events
Aug 31, 2023 Aug 25, 2023
8-K Current report
Other events
Jun 29, 2023 Jun 28, 2023
8-K Current report
Other events
Mar 27, 2023 Mar 27, 2023
8-K Current report
Other events
Feb 15, 2023 Feb 13, 2023
8-K Current report
Other events
Feb 3, 2023 Feb 2, 2023
8-K Current report
Other events
Jan 31, 2023 Jan 31, 2023
8-K Current report
Other events
Jan 20, 2023 Jan 15, 2023
8-K Current report
Other events
Dec 1, 2022 Dec 1, 2022
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure, Other events
Oct 18, 2022 Oct 12, 2022
8-K Current report
Material agreement, Officer or director change, Other events
Sep 30, 2022 Sep 26, 2022
8-K Current report
Bylaw or fiscal year change, Other events
Sep 15, 2022 Sep 14, 2022
8-K Current report
Shareholder vote results
Mar 11, 2022 Mar 11, 2022
8-K Current report
Other events
Mar 7, 2022 Mar 7, 2022
8-K Current report
Officer or director change
Jan 4, 2022 Dec 29, 2021
8-K Current report
Material agreement
Oct 27, 2021 Oct 1, 2021
8-K Current report
Material agreement
Sep 27, 2021 Sep 21, 2021
8-K Current report
Other events
Aug 18, 2021 Aug 17, 2021
8-K Current report
Material agreement, Other events
Jul 12, 2021 Jul 6, 2021
8-K Current report
Material agreement
Jun 7, 2021 Jun 1, 2021
8-K Current report
Material agreement, Other events
Apr 28, 2021 Apr 22, 2021
8-K Current report
Material agreement, Unregistered share sale
Apr 16, 2021 Apr 12, 2021
8-K Current report
Material agreement, Other events
Apr 7, 2021 Apr 6, 2021
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Mar 12, 2021 Mar 10, 2021
8-K Current report
Material agreement
Feb 16, 2021 Feb 12, 2021
8-K/A Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Feb 12, 2021 Feb 9, 2021
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Feb 10, 2021 Feb 9, 2021
8-K Current report
Officer or director change
Jan 28, 2021 Jan 18, 2021
8-K Current report
Material agreement
Jan 11, 2021 Jan 5, 2020
8-K Current report
Material agreement, Other events
Jan 11, 2021 Jan 5, 2021
8-K Current report
Material agreement, Other events
Dec 4, 2020 Dec 1, 2020
8-K Current report
Regulation FD disclosure
Oct 20, 2020 Oct 20, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change, Other events
Oct 6, 2020 Sep 24, 2020
8-K Current report
Material agreement, Unregistered share sale
Apr 29, 2020 Apr 28, 2020
8-K/A Amended current report
Material agreement, Unregistered share sale, Officer or director change
Apr 22, 2020 Apr 15, 2020
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
Apr 21, 2020 Apr 15, 2020
8-K Current report
Officer or director change
Jan 22, 2020 Jan 16, 2020
8-K Current report
Auditor change
Jan 22, 2019 Jan 17, 2019
8-K Current report
Material agreement, Acquisition or sale of assets
Dec 20, 2018 Dec 13, 2018
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
Sep 28, 2018 Sep 28, 2018
8-K Current report
Officer or director change
Jun 1, 2018 May 31, 2018
8-K Current report
Auditor change
Jul 21, 2016 Jul 14, 2016
8-K Current report
Auditor change
Jul 14, 2016 Jul 12, 2016
8-K Current report
Officer or director change
Feb 18, 2016 Feb 10, 2016
8-K Current report
Officer or director change
Nov 27, 2015 Nov 27, 2015
8-K Current report
Officer or director change
Jul 24, 2015 Jul 23, 2015
8-K Current report
Regulation FD disclosure
Jun 3, 2015 Jun 3, 2015
8-K Current report
Shareholder vote results
May 21, 2015 May 20, 2015
8-K Current report
Regulation FD disclosure
Nov 19, 2014 Nov 19, 2014
8-K Current report
Unregistered share sale, Officer or director change
Aug 1, 2014 Jul 30, 2014
8-K Current report
Auditor change
Mar 6, 2014 Mar 5, 2014
8-K Current report
Regulation FD disclosure
Dec 20, 2013 Dec 20, 2013
8-K Current report
Unregistered share sale, Other events
Oct 4, 2013 Sep 30, 2013
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Apr 30, 2013 Apr 24, 2013
8-K Current report
Officer or director change, Shareholder vote results
Jan 30, 2013 Jan 24, 2013

Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SILO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Sarasota, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1514183
Former names
Uppercut Brands, Inc. (until Aug 14, 2020); Point Capital, Inc. (until May 14, 2019); Gold Swap Inc (until Jan 7, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.